Z. Binal Et Al. , "Cross-talk between ribosome biogenesis, translation, and mTOR in CD133+4/CD44+prostate cancer stem cells," CLINICAL & TRANSLATIONAL ONCOLOGY , vol.22, no.7, pp.1040-1048, 2020
Binal, Z. Et Al. 2020. Cross-talk between ribosome biogenesis, translation, and mTOR in CD133+4/CD44+prostate cancer stem cells. CLINICAL & TRANSLATIONAL ONCOLOGY , vol.22, no.7 , 1040-1048.
Binal, Z., Acikgoz, E., Kizilay, F., Oktem, G., & Altay, B., (2020). Cross-talk between ribosome biogenesis, translation, and mTOR in CD133+4/CD44+prostate cancer stem cells. CLINICAL & TRANSLATIONAL ONCOLOGY , vol.22, no.7, 1040-1048.
Binal, Z. Et Al. "Cross-talk between ribosome biogenesis, translation, and mTOR in CD133+4/CD44+prostate cancer stem cells," CLINICAL & TRANSLATIONAL ONCOLOGY , vol.22, no.7, 1040-1048, 2020
Binal, Z. Et Al. "Cross-talk between ribosome biogenesis, translation, and mTOR in CD133+4/CD44+prostate cancer stem cells." CLINICAL & TRANSLATIONAL ONCOLOGY , vol.22, no.7, pp.1040-1048, 2020
Binal, Z. Et Al. (2020) . "Cross-talk between ribosome biogenesis, translation, and mTOR in CD133+4/CD44+prostate cancer stem cells." CLINICAL & TRANSLATIONAL ONCOLOGY , vol.22, no.7, pp.1040-1048.
@article{article, author={Z. Binal Et Al. }, title={Cross-talk between ribosome biogenesis, translation, and mTOR in CD133+4/CD44+prostate cancer stem cells}, journal={CLINICAL & TRANSLATIONAL ONCOLOGY}, year=2020, pages={1040-1048} }